Evidence map›Paper›PMID 20510234›Full record

ReviewRheumatic diseases clinics of North America2010

Innate immunity and rheumatoid arthritis.

Angelica Gierut, Harris Perlman, Richard M Pope

Open access · greenAbstract readReview
In one paragraph

Review in Rheumatic diseases clinics of North America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 124 citations in OpenAlex.

  1. Trial
  2. Trial
  3. The role of DAP12 in immune-related inflammatory diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  4. Article
  5. Review
  6. Depleting Autoreactive B‑Cells Using Targeted Photodynamic Therapy.ACS pharmacology & translational science · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Pyroptosis in bone loss.Apoptosis : an international journal on programmed cell death · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Angelica GierutDivision of Rheumatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, 240 East Huron Street, McGaw M300, Chicago, IL 60611, USA.
Harris Perlman
Richard M Pope
Northwestern University · US

Funding

Therapeutic Role for P21 in Suppressing IL-1 Beta Mediated PathologiesR01AR050250 · NIAMS · SAINT LOUIS UNIVERSITY · PI PERLMAN, HARRIS R · 2003 to 2014
$3.0M
Role of BH3-Domain Proteins in the Effector Phase of RAR01AR054796 · NIAMS · SAINT LOUIS UNIVERSITY · PI PERLMAN, HARRIS R · 2008 to 2012
$1.8M
Role of Stress-Response Protein gp96 in the Persistence of Rheumatoid ArthritisR01AR055240 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI POPE, RICHARD M. · 2008 to 2012
$1.7M
The role of Mcl-1 in the macrophages and RAR01AR049217 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI POPE, RICHARD M. · 2003 to 2007
$1.3M
The role BH3 and multi BH domain genes in regulating monocyte survival and functiR21AI067590 · NIAID · SAINT LOUIS UNIVERSITY · PI PERLMAN, HARRIS R · 2007 to 2008
$407k
NIAID NIH HHS AI067590NIAID NIH HHS R21 AI067590NIAMS NIH HHS AR049217NIAMS NIH HHS AR050250NIAMS NIH HHS AR054796NIAMS NIH HHS R01 AR049217NIAMS NIH HHS R01 AR050250NIAMS NIH HHS R01 AR054796NIAMS NIH HHS R01 AR055240
6 · The paper itself

Abstract

Innate immunity, with macrophages playing a central role, is critically important in the pathogenesis of RA. Although environmental insults such as smoking have been implicated in the initiation of rheumatoid arthritis (RA) in patients who express the shared epitope, the understanding of the role of innate immunity in the pathogenesis of this disease is also expanding. As the understanding continues to expand, enticing targets for new therapeutic interventions continue to be identified. This article focuses on cells of myelomonocytic origin, their receptors, and factors that interact with them.

Indexed as

AnimalsArthritis, RheumatoidFibroblastsHumansImmunity, InnateMacrophagesMonocytes

Identifiers

PMID20510234
PMCPMC2937347
OpenAlexW2000940419

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.